This article is more than 5 years old. Information may no longer be current.
FDA clears OrthoSensor knee system
OrthoSensor has received 510(k) clearance from the FDA for its Verasense Knee System with limb alignment.
The Verasense Knee System replaces the standard plastic tibial trial spacer used during knee replacement surgery, according to a company press release. As a result, surgeons have a more accurate sense of limb alignment, implant position and soft tissue balance during knee replacement surgery in one complete system. Integrating seamlessly within the current surgical workflow, Verasense is compatible for use with multiple knee implant systems.
“Traditionally, surgeons have relied on conventional instruments, personal judgment and experience to assess soft tissue balance and limb alignment. Verasense advances surgeon decision-making from a feel-based art, to a quantifiable science with a low-cost, easy to adopt solution that benefits all health system stakeholders and the patients they serve,” Jay Pierce, chief executive officer of OrthoSensor, stated in the release.